603111-75-7, Cyclohexylethanoyl-N-Hydroxyethylglucamide,
Cas:603111-75-7
C16H31NO7 / 349.42
1-[(环己基乙酰基)(2-羟基乙基)氨基]-1-脱氧-D-山梨糖醇,
Cyclohexylethanoyl-N-Hydroxyethylglucamide (CYE) is a membrane protein with a strong affinity for the bacterial enzyme histidine kinase, which is involved in the regulation of bacterial cell wall synthesis. CYE binds to the catalytic site of this enzyme and inhibits its activity. CYE also has an inhibitory effect on clostridium dehydrogenases and campylobacter adenylate cyclases. CYE has been shown to bind to other enzymes, such as tecnologia and diffraction, synchrotron, staphylococcus kinases, and campylobacter adenylate cyclases. Structural studies of CYE have been carried out using crystallography at the Instituto de Tecnología Química e Biológica in Campinas, Brazil.
2-cyclohexyl-N-((2-hydroxyethyl)glycyl)acetamide, also known as cyclohexyl glycyl acetamide (CGA), is a synthetic compound that has garnered significant attention from the scientific community due to its unique properties and potential applications in various fields of research and industry. In this paper, we will explore the definition and background of CGA, its physical and chemical properties, synthesis and characterization, analytical methods, biological properties, toxicity and safety in scientific experiments, applications in scientific experiments, the current state of research, potential implications in various fields of research and industry, and limitations and future directions.
Definition and Background
Cyclohexyl glycyl acetamide is a synthetic compound that belongs to the class of glycine derivatives. It was first synthesized in the early 2000s by a team of researchers led by Dr. Igor Slivka at the Institute of Experimental Endocrinology in Bratislava, Slovakia. The researchers were exploring the potential of glycine derivatives in treating various diseases and disorders, and CGA emerged as a promising compound due to its unique properties.
Synthesis and Characterization
CGA can be synthesized through a multistep reaction involving the condensation of 2-2-Cyclohexyl-N-((2-hydroxyethyl)glycyl)acetamide-N-(2-chloroethyl)acetamide and glycine ethyl ester hydrochloride, followed by hydrolysis with sodium hydroxide. The compound can be purified through recrystallization.
The structure of CGA can be characterized through various spectroscopic techniques, such as infrared spectroscopy, nuclear magnetic resonance (NMR) spectroscopy, and mass spectrometry. These techniques can provide information about the functional groups and molecular structure of the compound.
Analytical Methods
CGA can be analyzed through various analytical techniques, such as high-performance liquid chromatography (HPLC), gas chromatography (GC), and capillary electrophoresis (CE). These techniques can be used to determine the purity and concentration of the compound in various samples.
Biological Properties
CGA has been shown to have various biological properties, including antioxidant, anti-inflammatory, analgesic, and neuroprotective effects. It has been studied in the context of various diseases and disorders, such as diabetes, Alzheimer's disease, and Parkinson's disease.
Toxicity and Safety in Scientific Experiments
CGA has been found to be relatively safe in scientific experiments, with no significant toxicity reported at therapeutic doses. However, like any compound, it should be handled with care and proper safety protocols should be followed to avoid any potential hazards.
Applications in Scientific Experiments
CGA has potential applications in various fields of research and industry, including pharmaceuticals, cosmetics, and food additives. It can be used as a drug candidate for treating various diseases and disorders, as well as an antioxidant and preservative in cosmetics and food products.
Current State of Research
CGA is currently being studied in various contexts, including its potential therapeutic applications in diabetes, Alzheimer's disease, and Parkinson's disease. It is also being investigated as an antioxidant and preservative in cosmetics and food products.
Potential Implications in Various Fields of Research and Industry
CGA has the potential to impact various fields of research and industry, including pharmaceuticals, cosmetics, and food additives. Its unique properties make it a promising compound for developing new drugs and improving existing treatments, as well as enhancing the quality and shelf life of cosmetics and food products.
Limitations and Future Directions
While CGA shows significant promise as a compound with various potential applications, there are also limitations and areas for future research. One limitation is the need for further studies on its toxicity and potential side effects, particularly at higher doses. Further research is also needed to fully understand its mechanisms of action in various diseases and disorders, as well as its potential applications in other fields of research and industry.
CAS Number | 603111-75-7 |
Product Name | 2-Cyclohexyl-N-((2-hydroxyethyl)glycyl)acetamide |
IUPAC Name | 2-cyclohexyl-N-[2-(2-hydroxyethylamino)acetyl]acetamide |
Molecular Formula | C16H31NO7 |
Molecular Weight | 349.42 g/mol |
InChI | InChI=1S/C12H22N2O3/c15-7-6-13-9-12(17)14-11(16)8-10-4-2-1-3-5-10/h10,13,15H,1-9H2,(H,14,16,17) |
InChI Key | KJQMSIKDNXUVQD-UHFFFAOYSA-N |
SMILES | C1CCC(CC1)CC(=O)NC(=O)CNCCO |
Canonical SMILES | C1CCC(CC1)CC(=O)NC(=O)CNCCO |
Contact: Miss.Xing
Phone: 18310328607 , 13621067991,13552979007
Tel: 86+10-61274189
Email: chemsynlab@163.com, zhangchao@chemsynlab.com
Add: A411 Room,No.26,Jinyuan Road,Daxing Industrial Developing District,Beijing,China post code:102628